Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apyx Medical Co. stock logo
APYX
Apyx Medical
$1.50
+13.6%
$1.70
$1.21
$7.97
$51.96M1.09145,516 shs187,561 shs
BrainsWay Ltd. stock logo
BWAY
BrainsWay
$5.03
+2.0%
$5.76
$1.38
$7.61
$83.70M1.2119,845 shs26,281 shs
CVRx, Inc. stock logo
CVRX
CVRx
$14.40
+0.8%
$19.24
$9.18
$33.13
$310.90M1.29144,438 shs119,882 shs
TELA Bio, Inc. stock logo
TELA
TELA Bio
$4.45
-0.4%
$5.77
$4.23
$11.26
$109.69M0.95134,968 shs85,296 shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apyx Medical Co. stock logo
APYX
Apyx Medical
+13.64%+13.64%+18.11%-34.50%-48.10%
BrainsWay Ltd. stock logo
BWAY
BrainsWay
+1.93%-0.40%-7.37%-17.68%+224.52%
CVRx, Inc. stock logo
CVRX
CVRx
+0.77%-8.34%-21.82%-50.68%+47.54%
TELA Bio, Inc. stock logo
TELA
TELA Bio
-0.45%-13.93%-18.20%-40.67%-52.61%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apyx Medical Co. stock logo
APYX
Apyx Medical
3.798 of 5 stars
3.54.00.04.20.01.70.6
BrainsWay Ltd. stock logo
BWAY
BrainsWay
2.6936 of 5 stars
3.35.00.00.02.80.80.6
CVRx, Inc. stock logo
CVRX
CVRx
2.0505 of 5 stars
3.51.00.00.01.93.30.6
TELA Bio, Inc. stock logo
TELA
TELA Bio
1.8872 of 5 stars
3.52.00.00.02.21.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apyx Medical Co. stock logo
APYX
Apyx Medical
3.00
Buy$6.17311.11% Upside
BrainsWay Ltd. stock logo
BWAY
BrainsWay
2.67
Moderate Buy$7.0039.17% Upside
CVRx, Inc. stock logo
CVRX
CVRx
3.00
Buy$33.67133.80% Upside
TELA Bio, Inc. stock logo
TELA
TELA Bio
3.00
Buy$13.67207.12% Upside

Current Analyst Ratings

Latest APYX, TELA, CVRX, and BWAY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
TELA Bio, Inc. stock logo
TELA
TELA Bio
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$15.00
3/22/2024
TELA Bio, Inc. stock logo
TELA
TELA Bio
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$15.00 ➝ $12.00
3/11/2024
BrainsWay Ltd. stock logo
BWAY
BrainsWay
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
1/26/2024
CVRx, Inc. stock logo
CVRX
CVRx
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$21.00 ➝ $33.00
1/26/2024
CVRx, Inc. stock logo
CVRX
CVRx
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$31.00 ➝ $36.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apyx Medical Co. stock logo
APYX
Apyx Medical
$52.35M0.99N/AN/A$0.78 per share1.92
BrainsWay Ltd. stock logo
BWAY
BrainsWay
$31.78M2.63N/AN/A$2.50 per share2.01
CVRx, Inc. stock logo
CVRX
CVRx
$39.29M7.91N/AN/A$3.65 per share3.95
TELA Bio, Inc. stock logo
TELA
TELA Bio
$58.45M1.88N/AN/A$0.77 per share5.78

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apyx Medical Co. stock logo
APYX
Apyx Medical
-$18.71M-$0.54N/AN/AN/A-35.75%-54.90%-28.41%5/9/2024 (Estimated)
BrainsWay Ltd. stock logo
BWAY
BrainsWay
-$4.20M-$0.13N/A62.88N/A-13.20%-10.05%-6.88%5/15/2024 (Estimated)
CVRx, Inc. stock logo
CVRX
CVRx
-$41.20M-$1.98N/AN/AN/A-104.85%-47.30%-35.88%4/30/2024 (Confirmed)
TELA Bio, Inc. stock logo
TELA
TELA Bio
-$46.66M-$2.07N/AN/AN/A-79.83%-201.62%-58.60%5/9/2024 (Estimated)

Latest APYX, TELA, CVRX, and BWAY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024N/A
CVRx, Inc. stock logo
CVRX
CVRx
-$0.53N/A+$0.53N/AN/AN/A  
3/21/2024Q4 2023
Apyx Medical Co. stock logo
APYX
Apyx Medical
-$0.13-$0.19-$0.06-$0.10$14.40 million$14.66 million
3/21/2024Q4 2023
TELA Bio, Inc. stock logo
TELA
TELA Bio
-$0.44-$0.53-$0.09-$0.53$16.65 million$17.00 million
3/6/202412/31/2023
BrainsWay Ltd. stock logo
BWAY
BrainsWay
-$0.03-$0.01+$0.02N/A$8.40 million$9.03 million    
1/25/2024Q4 2023
CVRx, Inc. stock logo
CVRX
CVRx
-$0.55-$0.44+$0.11-$0.44$10.90 million$11.31 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apyx Medical Co. stock logo
APYX
Apyx Medical
N/AN/AN/AN/AN/A
BrainsWay Ltd. stock logo
BWAY
BrainsWay
N/AN/AN/AN/AN/A
CVRx, Inc. stock logo
CVRX
CVRx
N/AN/AN/AN/AN/A
TELA Bio, Inc. stock logo
TELA
TELA Bio
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apyx Medical Co. stock logo
APYX
Apyx Medical
1.23
5.52
4.74
BrainsWay Ltd. stock logo
BWAY
BrainsWay
N/A
5.68
5.30
CVRx, Inc. stock logo
CVRX
CVRx
0.38
14.25
12.86
TELA Bio, Inc. stock logo
TELA
TELA Bio
2.15
4.23
3.45

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Apyx Medical Co. stock logo
APYX
Apyx Medical
55.33%
BrainsWay Ltd. stock logo
BWAY
BrainsWay
30.11%
CVRx, Inc. stock logo
CVRX
CVRx
75.27%
TELA Bio, Inc. stock logo
TELA
TELA Bio
94.35%

Insider Ownership

CompanyInsider Ownership
Apyx Medical Co. stock logo
APYX
Apyx Medical
13.10%
BrainsWay Ltd. stock logo
BWAY
BrainsWay
19.00%
CVRx, Inc. stock logo
CVRX
CVRx
18.30%
TELA Bio, Inc. stock logo
TELA
TELA Bio
5.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Apyx Medical Co. stock logo
APYX
Apyx Medical
25234.64 million30.11 millionOptionable
BrainsWay Ltd. stock logo
BWAY
BrainsWay
13416.64 million13.48 millionNot Optionable
CVRx, Inc. stock logo
CVRX
CVRx
20021.59 million17.64 millionOptionable
TELA Bio, Inc. stock logo
TELA
TELA Bio
22724.65 million23.25 millionOptionable

APYX, TELA, CVRX, and BWAY Headlines

SourceHeadline
TELA Bio Launches Innovative Hernia Repair Device in the U.S. MarketTELA Bio Launches Innovative Hernia Repair Device in the U.S. Market
msn.com - April 17 at 9:16 AM
TELA Bio launches OviTex IHR for inguinal hernia repair in USTELA Bio launches OviTex IHR for inguinal hernia repair in US
msn.com - April 16 at 5:32 PM
TELA Bio announces US launch OviTex IHR for use in laparoscopic and robotic-assisted inguinal hernia repairTELA Bio announces US launch OviTex IHR for use in laparoscopic and robotic-assisted inguinal hernia repair
pharmabiz.com - April 16 at 7:29 AM
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia ProceduresTELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
globenewswire.com - April 15 at 7:00 AM
MDXG: Legal AvenuesMDXG: Legal Avenues
finance.yahoo.com - April 11 at 1:10 PM
TELA Bio Appoints Esteemed Surgeon Dr. Howard N. Langstein as Vice President of Medical AffairsTELA Bio Appoints Esteemed Surgeon Dr. Howard N. Langstein as Vice President of Medical Affairs
msn.com - April 10 at 6:58 AM
TELA Bio, Inc.: TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon StrategyTELA Bio, Inc.: TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
finanznachrichten.de - April 8 at 4:17 PM
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon StrategyTELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
globenewswire.com - April 8 at 7:00 AM
TELA Bio Stands Tall With Consistent Growth, Novel Products, and a Promising Revenue Projection for 2024TELA Bio Stands Tall With Consistent Growth, Novel Products, and a Promising Revenue Projection for 2024
msn.com - March 25 at 8:23 AM
Analysts Are Updating Their TELA Bio, Inc. (NASDAQ:TELA) Estimates After Its Full-Year ResultsAnalysts Are Updating Their TELA Bio, Inc. (NASDAQ:TELA) Estimates After Its Full-Year Results
finance.yahoo.com - March 24 at 5:22 PM
TELA Bio, Inc. (TELA) Q4 2023 Earnings Call TranscriptTELA Bio, Inc. (TELA) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 23 at 11:14 PM
TELA Bio Full Year 2023 Earnings: US$2.04 loss per share (vs US$2.72 loss in FY 2022)TELA Bio Full Year 2023 Earnings: US$2.04 loss per share (vs US$2.72 loss in FY 2022)
finance.yahoo.com - March 23 at 8:39 AM
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX(TM) - the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia SurgeryTELA Bio Announces U.S. Commercial Launch of LIQUIFIX(TM) - the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
stockhouse.com - March 22 at 5:36 PM
TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call TranscriptTELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 22 at 5:36 PM
Q4 2023 TELA Bio Inc Earnings CallQ4 2023 TELA Bio Inc Earnings Call
finance.yahoo.com - March 22 at 7:36 AM
Recap: TELA Bio Q4 EarningsRecap: TELA Bio Q4 Earnings
benzinga.com - March 21 at 9:14 PM
TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023
msn.com - March 21 at 9:14 PM
TELA Bio Inc Reports Robust Revenue Growth in Q4 and Full Year 2023TELA Bio Inc Reports Robust Revenue Growth in Q4 and Full Year 2023
finance.yahoo.com - March 21 at 9:14 PM
TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue EstimatesTELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates
zacks.com - March 21 at 6:31 PM
Strategic Divestiture and Innovative Product Launch Fuel Buy Rating for TELA BioStrategic Divestiture and Innovative Product Launch Fuel Buy Rating for TELA Bio
markets.businessinsider.com - March 21 at 4:13 PM
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial ResultsTELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
finance.yahoo.com - March 21 at 4:13 PM
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial ResultsTELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
globenewswire.com - March 21 at 4:05 PM
Tela Bio Announces Commercial Launch Of Liquifix Devices In U.S.Tela Bio Announces Commercial Launch Of Liquifix Devices In U.S.
markets.businessinsider.com - March 21 at 10:07 AM
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia SurgeryTELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
globenewswire.com - March 21 at 7:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Apyx Medical logo

Apyx Medical

NASDAQ:APYX
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. Its Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also develops and manufactures hand pieces for open and laparoscopic procedures; and OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
BrainsWay logo

BrainsWay

NASDAQ:BWAY
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
CVRx logo

CVRx

NASDAQ:CVRX
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
TELA Bio logo

TELA Bio

NASDAQ:TELA
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.